Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The two windows in practice: Whichever ends first determines the safe-use period
Key risks include pancreatitis, gallbladder disease, potential thyroid C-cell tumours, and altered levothyroxine requirements due to weight changes
Neither injection is a weight-loss treatment
In Phase 3 clinical trials, retatrutide has been studied as a once-weekly injection, starting at 2mg once weekly and increasing gradually every four weeks
1 This comes after Hims & Hers was barred from selling compounded GLP-1 medications earlier this year
US$ 28.41
US$ 22.96
US$ 27.71
US$ 28.96
US$ 20.17
